In vivo stability of supramolecular host–guest complexes monitored by dual-isotope multiplexing in a pre-targeting model of experimental liver radioembolization-Reference-Cited by-同舟云学术

In vivo stability of supramolecular host–guest complexes monitored by dual-isotope multiplexing in a pre-targeting model of experimental liver radioembolization

Published:2019-01 Issue: Volume:293 Page:126-134
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Welling Mick M.,Spa Silvia J.,van Willigen Danny M.,Rietbergen Daphne D.D.,Roestenberg Meta,Buckle Tessa,van Leeuwen Fijs W.B.^ORCID

Funder

European Research Council (ERC)

Netherlands Organization for Scientific Research

Society of Nuclear Medicine and Molecular Imaging

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2012

2. Radioembolization of colorectal liver metastases: indications, technique, and outcomes;Boas;J. Nucl. Med.,2017

3. SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (plus or minus Bevacizumab) versus mFOLFOX6 (plus or minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer;van Hazel;J. Clin. Oncol.,2016

4. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials;Wasan;Lancet Oncol.,2017

5. Hepatocellular carcinoma: risk factors, diagnosis and treatment;Janevska;Open Access. Maced. J. Med. Sci.,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic host-guest pairs as novel bioorthogonal tools for pre-targeting;Chinese Chemical Letters;2024-02

2. Biodistribution of Radioactively Labeled Splice Modulating Antisense Oligonucleotides After Intracerebroventricular and Intrathecal Injection in Mice;Nucleic Acid Therapeutics;2024-02-01

3. Exploring the Potential of Nanogels: From Drug Carriers to Radiopharmaceutical Agents;Advanced Healthcare Materials;2023-09-28

4. Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy;Frontiers in Medicine;2023-06-27

5. Controlled drug delivery mediated by cyclodextrin-based supramolecular self-assembled carriers: From design to clinical performances;Carbohydrate Polymer Technologies and Applications;2023-06